OBJECTIVE: To determine the feasibility of using a biomarker panel of myoglobin, creatinine kinase MB (CK-MB) and cardiac troponin I (cTnI) to identify patients with suspected acute coronary syndrome (ACS) who are suitable for discharge within 2 h. METHODS: We took blood at presentation and at 2 h f...
No comments yet
Be the first to share your thoughts!